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1080 Noninvasive evaluation of internal thoracic artery and left anterior
descending coronary artery anastomotic sites using transthoracic Doppler
echocardiography: Comparison with coronary arteriography
Nobuaki Hirata, MD, Nobuaki Asaoka, PhD, Akira Amemiya, MD, Shinichi Hatsuoka, MD,
Takayoshi Ueno, MD, and Yoshio Kosakai, MD, Hyogo, Japan
Transthoracic Doppler echocardiography allowed the detection of the ITA, LAD, and
anastomotic sites, as well as an accurate measurement of blood flow velocity, in over 80% of
our patients. This totally noninvasive method compares favorably with coronary arteriography
and is considered to be reliable.
1087 A randomized trial of aprotinin (Trasylol) on blood loss, blood product
requirement, and myocardial injury in total arterial grafting }
David P. Taggart, MD (Hons), PhD, FRCS, Veronica Djapardy, BM, BCh, Madhav Naik, MB,
and Amanda Davies, RCN, Oxford, United Kingdom
Aprotinin significantly reduces blood loss and the need for blood component transfusion in
patients undergoing total arterial grafting without increasing the risk of myocardial injury.
Aprotinin should be considered for routine use in patients undergoing total arterial grafting, but
cautiously in patients with an elevated preoperative creatinine.
1095 The effect of the maze procedure on the secretion of arginine-vasopressin
and aldosterone
Niv Ad, MD, Ying Y. Tian, PhD, Joseph Verbalis, MD, Scott D. Imahara, BS, and
James L. Cox, MD, Washington, DC
The maze procedure has been demonstrated to be a safe and effective treatment for medically
refractory atrial fibrillation. However, excessive fluid retention is still a major complication
after the procedure. Plasma levels of arginine vasopressin and aldosterone were significantly
higher in patients after the maze procedure when compared with patients after coronary artery
bypass grafting, which indicates that arginine vasopressin and aldosterone, rather than atrial
natriuretic peptide alone, participate in the excessive postoperative fluid retention that follows
the maze procedure.
1101 Generation of platelet-derived microparticles in patients undergoing cardiac
surgery is not affected by complement activation
Jeanette M. van den Goor, MSc, CP, Albert van den Brink, MD, Rienk Nieuwland, PhD,
Willem van Oeveren, PhD, Peter M. Rutten, CP, Robert Tepaske, MD, Jan G. Tijssen, PhD,
Augueste Sturk, PhD, Bas A. de Mol, MD, PhD, and Leo´n Eijsman, MD, PhD, Amsterdam and
Groningen, The Netherlands
The relationship between complement activation and concentrations of circulating platelet-
derived microparticles was evaluated in patients undergoing cardiac surgery with
cardiopulmonary bypass with uncoated or coated (BioPassive or BioActive surface)
oxygenators. Despite complement activation during cardiopulmonary bypass, no relationship
was present between complement activation and numbers of circulating platelet-derived
microparticles.
Table of Contents (continued)
(continued on page 24A)
22A The Journal of Thoracic and Cardiovascular Surgery ● October 2003
ED
ITO
RIA
L
A
CD
CH
D
CSP
G
TS
TX
